Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy? [PDF]
Bharathi Reddy, Arlene B. Chapman
openalex +1 more source
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database [PDF]
Paul B. Watkins+10 more
openalex +1 more source
Efficacy of Tolvaptan in Patients with Volume Overload after Cardiac Surgery [PDF]
Kenichiro Noguchi+6 more
openalex +1 more source
Adapting The Adpkd Outcomes Model to Predict Cost Consequence In Italian Patients With Autosomal Dominant Polycystic Kidney Disease (Adpkd) Treated With Jinarc (Tolvaptan) [PDF]
F.S. Mennini+5 more
openalex +1 more source
Efficacy and safety of tolvaptan in treatment of SIADH; case-series from 2 UK hospitals [PDF]
Ploutarchos Tzoulis+4 more
openalex +1 more source
The use of intermittent 7.5 mg tolvaptan on an out-patient basis for SIADH: a retrospective audit from a tertiary cancer hospital [PDF]
Mohit Kumar+3 more
openalex +1 more source
Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients [PDF]
Michele Umbrello+8 more
openalex +1 more source
Severe tolvaptan-associated hyperglycemia: a case report. [PDF]
Sun H+5 more
europepmc +1 more source